Ignite Creation Date:
2024-07-17 @ 11:12 AM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06480526
Status:
RECRUITING
Last Update Posted:
2024-07-01
First Post:
2024-06-14
Brief Title:
Feasibility of Screening for Early Late Effects of Contemporary Therapy in High-Risk Neuroblastoma Survivors
Sponsor:
St Jude Childrens Research Hospital
Organization:
St Jude Childrens Research Hospital
Study Overview
Official Title:
LEGACY Late Effects of GD2 Antibody and Chemotherapy in Youths Feasibility of Screening for Early Late Effects of Contemporary Therapy in High-Risk Neuroblastoma Survivors
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study participant is being asked to be in a research study called LEGACY because you were treated for high-risk neuroblastoma HR-NBL
Primary Objective
To determine the feasibility of conducting comprehensive evaluations leveraging the established SJLIFE St Jude Lifetime Cohort Study study infrastructure in survivors of HR-NBL high-risk neuroblastoma who are greater than 2 years from completion of contemporary therapy and were previously treated at SJCRH St Jude Childrens Research Hospital
Exploratory Objectives
To describe the health outcomes of survivors of HR-NBL previously treated at SJCRH with contemporary era therapy who are greater than 2 years from completion of therapy
To describe the relationship between patient outcomes and social determinants of health SDOH in survivors of HR-NBL previously treated at SJCRH with contemporary era therapy who are greater than 2 years from completion of therapy
Primary Objective
To determine the feasibility of conducting comprehensive evaluations leveraging the established SJLIFE St Jude Lifetime Cohort Study study infrastructure in survivors of HR-NBL high-risk neuroblastoma who are greater than 2 years from completion of contemporary therapy and were previously treated at SJCRH St Jude Childrens Research Hospital
Exploratory Objectives
To describe the health outcomes of survivors of HR-NBL previously treated at SJCRH with contemporary era therapy who are greater than 2 years from completion of therapy
To describe the relationship between patient outcomes and social determinants of health SDOH in survivors of HR-NBL previously treated at SJCRH with contemporary era therapy who are greater than 2 years from completion of therapy
Detailed Description:
The study participant will have blood tests tests to measure how your nervous system and stomach works and an ultrasound of your liver for this study The researchers will test how well your heart and blood vessels are working
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NCI-2024-05183 | REGISTRY | None | None |